Fill out the form below and an Althea Representative will contact you promptly.

All fields required.

Areas of Interest (Check all that apply)
Let’s Make Headlines

Featured Article

Ajinomoto Althea, Inc. Opens Manufacturing Suites in New High Potency and Antibody Drug Conjugate Commercial Facility

SAN DIEGO – September 19, 2017 —  Ajinomoto Althea, Inc. (“Althea”), a leading provider of biopharmaceutical contract development and manufacturing services, today announced it will soon open a GMP production suite in its newly constructed High Potency Products (HPP) commercial manufacturing facility located in San Diego, CA. Althea took ownership of the new facility on…

Read Article

Press Releases

Ajinomoto Althea, Inc. Announces New Aseptic Fill Finish Line

Read Article

CEO J. David Enloe Awarded ‘Most Admired CEO

Read Article

Ajinomoto Althea, Inc. Appoints Dr. Lori McDonald as Vice President of Compliance

Read Article

Biologics candidate manufactured using Ajinomoto Co., Inc.’s CORYNEX® Protein Expression System enters clinical trials for the first time

Read Article

Ajinomoto Althea, Inc. Announces Issuance of New US Patent for Manufacturing of Crystal Monoclonal Antibodies

Read Article

Ajinomoto Althea, Inc. Expands Its Capacity of Fill Finish Manufacturing with Addition of Second Shift

Read Article

Ajinomoto Althea, Inc. Launches Process and Analytical Development Services for Antibody Drug Conjugates (ADCs) Therapeutics

Read Article

Ajinomoto Althea, Inc. Expands Manufacturing Capabilities to ADC Fill Finish and Bioconjugation

Read Article

Ajinomoto Althea, Inc. Awarded CA Tax Credit

Read Article

Ajinomoto Althea, Inc. Receives European GMP Certification for Commercial Aseptic Filling and Testing

Read Article

Althea’s New Drug Formulation Technology Gains Attention from Two More Top Pharmaceutical Companies

Read Article

Althea Rebrands To Elevate Its Promise to Clients

Read Article

Ajinomoto Althea, Inc. Receives European GMP Certification

Read Article

Ajinomoto Althea Inc. Now Offering A Novel Protein Production Platform: Corynex®

Read Article

Ajinomoto Althea Inc. Appoints J. David Enloe as President and Chief Executive Officer

Read Article

Ajinomoto Althea, Inc. Selected as a Finalist in 26th Annual CONNECT Most Innovative New Product Awards

Read Article

Ajinomoto Co., Inc. Completes Acquisition of Althea Technologies, Inc

Read Article

Ajinomoto Co., Inc. Agrees to Acquire Althea Technologies, Inc.

Read Article

Althea Technologies & Profectus Biosciences Sign Manufacturing Agreement for Plasmid DNA Production

Read Article

Pfenex Inc. Awards Althea Technologies a Contract for cGMP Manufacturing of Circumsporozoite Protein from Plasmodium falciparum, a Key Malaria Antigen

Read Article

Althea Technologies Announces Expanded Roles for Key Executives

Read Article
Back to top